Springer Nature AG & Co. KGaA
20.60
EUR
+0.05
(+0.24%)
ISIN
DE000SPG1003
Return %
Stock
S&P 500
1Y
-10.04
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Frank Vrancken Peeters
- Full Time Employees
- 9,424
- Sector
- Consumer services
- Industry
- Publishing: books/magazines
- Address
- Heidelberger Platz 3 Berlin BE Germany 14197
- IPO Date
- Oct 4, 2024
- Website
- springer.com
- Similar Companies
- Business
- Springer Nature AG & Co. KGaA operates as a global research, health, educational, and professional publisher headquartered in Berlin, Germany, with a founding date tracing back to 1842 through its Springer imprint. The company publishes a comprehensive range of science, technology, engineering, mathematics, medical, and social sciences content via academic journals, books, monographs, textbooks, handbooks, reference works, and digital eBook formats under prominent brands including Nature, Springer, Palgrave Macmillan, and Adis. Its products and services encompass research journals, open access articles, scientific discovery platforms, research author services, medical education and pharmaceutical training materials, customized publishing content, specialist information services, and English language teaching and K12 educational curriculum materials, serving research and academic libraries, government agencies, healthcare sectors, and corporate clients worldwide. Recent major developments include the company’s milestone of publishing 50% of its primary research articles as open access by 2024, solidifying its leadership in open science and enhanced research accessibility. Springer Nature continues to invest heavily in technology and artificial intelligence, with a €177 million investment in 2024 to accelerate and improve the publishing process, including AI-based reviewer assistant tools and programs to detect fraudulent content. In the healthcare sector, it launched AskAdis, a conversational AI interface tailored for pharmaceutical markets. The company is also advancing sustainability by supporting the UN’s Sustainable Development Goals, targeting carbon neutrality, and organizing its publications around 17 SDG-related content hubs. Additionally, Springer Nature plans to go public on the Frankfurt Stock Exchange, aiming to enhance governance with a diverse supervisory board and implement a dividend policy reflecting strong cash flow generation. Operating across approximately 200 offices in 45 countries, Springer Nature is recognized as the world’s largest academic book publisher and a leading publisher of influential journals including the elite Nature portfolio. Its broad target markets include academic researchers, healthcare professionals, governmental research organizations, and educational institutions globally. Springer Nature is a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH and is actively expanding its digital and AI-enabled publishing capabilities to support robust academic and scientific communication and research innovation worldwide.